Rossari Biotech Ltd · NSE:ROSSARI
Rossari Biotech — Q3 FY25 Earnings Presentation
28 slides from Rossari Biotech's earnings presentation, Jan 22, 2025
Slide 1: Exchange filing cover letter for Q3 FY25 earnings presentation
January 22, 2025 DCS-CRD Listing Compliance BSE Limited National Stock Exchange of India Ltd. First Floor, New Trade Wing Exchange Plaza, 5th Floor Rotunda Building, Phiroze Jeejeebhoy Towers Plot No. C/1, ‘G’ Block, Bandra- Kurla Dalal Street, Fort Mumbai 400001 Complex Bandra East Mumbai 400051 Fa
Slide 2: Rossari Biotech Ltd. Q3 & 9M FY25 Results Presentation
Rossari Biotech Ltd. Q3 & 9M FY25 Results Presentation January 21, 2025
Slide 3: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of Rossari Biotech Ltd (Rossari) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to b
Slide 4: Q3 FY25 Results Overview, Company Overview, Annexure
Q3 FY25 Results Overview Company Overview Annexure 3
Slide 5: Q3 FY25 – Key Financial Highlights
Q3 FY25 – Key Financial Highlights Steady Quarterly Performance Highest Quarterly Revenue Steady Quarterly EBITDA Lower Quarterly PAT Revenue from Operations EBITDA PAT Business Sector (Rs. cr) (Rs. cr) (Rs. cr) contribution HPPC, 64.8 65.9 63.7 76% 512.7 498.3 35.3 463.8 34.4 31.7 Q3 FY25 TSC, AHN,
Slide 6: Past Financial Performance Snapshot
Past Financial Performance Snapshot Revenue (Rs. cr) EBITDA (Rs. cr) PAT (Rs. cr) CAGR – 11% CAGR – 16% CAGR – 16% 131 1,831 250 1,656 223 107 1,483 98 185 FY22 FY23 FY24 FY22 FY23 FY24 FY22 FY23 FY24 Exports (Rs. cr) ROE (%) ROCE (%) Net Debt to Equity (x) CAGR – 30% 24.0 448 21.0 21.0 380 0.04 265
Slide 7: Management Message
Management Message Commenting on the Q3 FY25 performance, in a joint statement, Mr. Edward Menezes, Promoter & Executive Chairman, and Mr. Sunil Chari, Promoter & Managing Director, said “We have navigated a dynamic operating environment in Q3 FY25, delivering resilient performance despite softer do
Slide 8: Key Developments
Key Developments Progress on Capacity Expansion Projects: • The Company is advancing its capacity expansion initiatives at the Dahej facility and through Unitop Chemicals to meet the growing demand for specialty chemicals across key segments • These projects are expected to be commissioned in the co
Slide 9: Abridged P&L Statement - Consolidated
Abridged P&L Statement - Consolidated Particulars (Rs. cr) Q3 FY25 Q3 FY24 Y-o-Y 9M FY25 9M FY24 Y-o-Y Revenues from Operations 512.7 463.8 10.5% 1500.7 1,357.8 10.5% Total Expenditure •COGS 350.0 323.0 8.4% 1031.6 955.2 8.0% •Employee benefits expense 35.7 26.0 37.3% 96.8 78.1 23.9% •Other expenses
Slide 10: Segment-wise Operating Performance
Segment-wise Operating Performance Quarterly Revenue Break-up (Rs. cr) Q3 FY25 Q2 FY25 Q3 FY24 513 498 464 390 390 356 95 84 83 28 24 25 HPPC TSC AHN TOTAL Shift (Y-o-Y) % 9.6% 14.5% 12.0% 10.5% Shift (Q-o-Q) % - 13.1% 16.7% 3.0% Note: 1) All figures, unless mentioned otherwise, are on a consolidate
Slide 11: Q3 FY25 Results Overview, Company Overview, Annexure
Q3 FY25 Results Overview Company Overview Annexure 10
Slide 12: Rossari – At a Glance
Rossari – At a Glance Technocrat promoters with 45+ 7* 332,100* 4* 29% 23% cumulative years of Manufacturing MTPA R&D Facilities Revenue CAGR % PAT CAGR % experience in the facilities Capacity Installed (FY19-24) (FY19-24) specialty chemicals industry Rossari – A Specialty-Chemical manufacturer prov
Slide 13: A 25-Year Journey of Transformation
A 25-Year Journey of Transformation Delivering Value and Maintaining Synergy Along the Way Looking back in time Our Company was initially incorporated as ‘Rossari Labtech’ in March, 2003, as a partnership firm. In the same year, in December, the name of the partnership firm was changed to ‘Rossari B
Slide 14: Business Overview
Business Overview One of the leading specialty chemicals manufacturer delivering differentiated & tailor-made solutions across Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC) and Animal Health and Nutrition (AHN) businesses HPPC TSC AHN • One of the fastest-gr
Slide 15: Strengthening Market Presence
Strengthening Market Presence Increasingly tapping new segments across domestic and international markets Building direct Growing client touch-points with base of over several clients 1,000 customers Strong and both India and long-standing International relationships with several clients and distrib
Slide 16: Robust Manufacturing Capabilities
Robust Manufacturing Capabilities Manufacturing Facility at Silvassa • Located on 8.6 acres of land • Fungible manufacturing capabilities for powders, granules and liquids • Facility has a comprehensive range of testing & packaging capabilities Unitop Dahej Plant • Effluent treatment facility, with
Slide 17: Growth Drivers
Growth Drivers 01 Augmenting product 02 Innovation and product 03 Seeding new business portfolio development lines • Enhance emphasis on green/sustainable • Strengthen innovation platform for • Evaluate opportunities based on existing solutions differentiated offerings capabilities and technical kno
Slide 18: Update on Key Subsidiaries
Update on Key Subsidiaries Executed synergistic acquisitions in the past complementing the ethos of Rossari’s business model Revenue (Rs. cr) CAGR – 20% • Unitop solutions sold across 25+ countries • Presence in high-potential Specialty chemical 651 554 454 Unitop Chemicals segments, such as Agroche
Slide 19: Strategic & value-accretive acquisitions accelerate growth and drive economies of scale
Key Synergies from Acquisitions Strategic & value-accretive acquisitions accelerate growth and drive economies of scale Augmented Expansion of Extension of Pooling together of Inorganic presence in addressable manufacturing related technologies investments within Specialty Chemical, domestic and exp
Slide 20: Strategies: Strategic Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 1. Expanding into New Business Lines • Leverage existing R&D capabilities and expertise in core chemistries to • Diversified revenue streams, reduced risk from dependence on core diversify into new product segments. segments. • Exp
Slide 21: Strategies: Strategic Responses to Opportunities
Strategies Strategic Responses to Opportunities Opportunity Outcomes 4. Enhancing Sustainability and Green Initiatives • Invest in research and development of advanced sustainable chemical • Strengthened brand reputation as an environmentally responsible solutions. company. • Explore opportunities i
Slide 22: Strategies: Strategic Responses to Threats
Strategies Strategic Responses to Threats Threats Outcomes 1. Increasing Competition • Entry of new players or intensified competition from existing rivals in the • Drive for innovation and development of differentiated products specialty chemicals market. • Improved operational efficiency and cost
Slide 23: Focus on Green & Sustainable Chemical Solutions since Inception
Focus on Green & Sustainable Chemical Solutions since Inception Specialists in producing environmentally-benign substitutes that replace legacy and harmful products Focus on green, sustainable and cost neutral products Minimizing carbon footprint of manufacturing processes while maximizing customer
Slide 24: Corporate Social Responsibility
Corporate Social Responsibility We at Rossari, recognize our role and responsibility to deliver superior and sustainable value to our customers, business partners, employees and communities. We have implemented various CSR initiatives with employee volunteers as well as in partnership with implement
Slide 25: Experienced Promoters and Board of Directors
Experienced Promoters and Board of Directors Founders & Promoters Independent Directors • Over 25 years of experience in the banking industry. He holds a bachelor’s degree in • B. Sc. (chemistry major) from K. J. Somaiya College of Science, commerce from H. L. Commerce College, Gujarat University. H
Slide 26: Conference Call Details
CONFERENCE CALL DETAILS Q3 F Y 2 0 2 5 Earnings C o n f er ence Call Time 05:00 PM IST on Thursday, January 23, 2025 Pre-registration To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Diamond Pass Registratio
Slide 27: About Us
About Us Rossari Biotech Limited (Rossari) (BSE: 543213, NSE: ROSSARI), is a Specialty-Chemicals manufacturer providing intelligent and sustainable solutions for customers across industries. Headquartered at Mumbai, India, the Company operates strategically located manufacturing facilities at Silvas
Slide 28: Thank you
Thank y#u